These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9445832)

  • 21. Treatment of osteoporosis: where are we and where are we going to.
    Reginster JY
    Morphologie; 1999 Jun; 83(261):41-5. PubMed ID: 10546235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
    Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC
    Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
    Rigalli A; Pera L; Morosano M; Masoni A; Bocanera R; Tozzini R; Puche RC
    Medicina (B Aires); 1999; 59(2):157-61. PubMed ID: 10413893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture.
    Fujita T; Ohue M; Fujii Y; Miyauchi A; Takagi Y
    J Bone Miner Metab; 2004; 22(1):32-8. PubMed ID: 14691684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of different doses of calcitonin on bone mineral density and fracture risk in postmenopausal osteoporosis.
    Hizmetli S; Elden H; Kaptanoglu E; Nacitarhan V; Kocagil S
    Int J Clin Pract; 1998 Oct; 52(7):453-5. PubMed ID: 10622084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium and vitamin D in the prevention and treatment of osteoporosis.
    Orcel P
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):70S-74S. PubMed ID: 9273942
    [No Abstract]   [Full Text] [Related]  

  • 31. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis].
    Scharla SH
    MMW Fortschr Med; 1999 Aug; 141(31-32):32-6. PubMed ID: 10726119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D; Charhon S; Edouard C; Meunier PJ
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluorides and bisphosphonates in the treatment of osteoporosis].
    Ringe JD
    Orthopade; 2001 Jul; 30(7):456-61. PubMed ID: 11515184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D and bone health in postmenopausal women.
    Malabanan AO; Holick MF
    J Womens Health (Larchmt); 2003 Mar; 12(2):151-6. PubMed ID: 12737713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The new concept of osteoporosis. Early diagnosis, prevention and therapy are possible today].
    Hesch RD; Harms H; Rittinghaus EF; Brabant G
    Fortschr Med; 1990 Apr; 108(11):219-21. PubMed ID: 2358288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fluoride therapy of osteoporosis].
    Ziegler R
    Ther Umsch; 1991 Feb; 48(2):84-90. PubMed ID: 2035171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.